Migraine Triggers Difficult to Pinpoint

Published Online: Monday, June 24, 2013
Follow Pharmacy_Times:
According to a study published online on March 27, 2013, in Headache, migraine sufferers may not be able to determine their migraine triggers. The researchers found that patients did not experience triggers under the exact same conditions, making it almost impossible to determine a trigger without statistical analysis.

Related Articles
Teva has launched the first generic version of Janssen’s Axert migraine treatment.
Opioids and barbiturates are commonly prescribed as first-line migraine treatments, even though clinical guidelines recommend them only as a last resort.
Children aged 12 to 17 years with migraines now have a new option for alleviating their symptoms.
The FDA today approved sumatriptan and naproxen sodium to treat migraines in patients aged 12 to 17 years.
Latest Issues
$auto_registration$